FORM 6-K

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

For the month of May 2019

 

FORMULA SYSTEMS (1985) LTD.

(Translation of registrant’s name into English)

 

5 HaPlada Street, Or-Yehuda, Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

 

Form 20-F ☒    Form 40-F ☐

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934

 

Yes ☐    No ☒

 

If “Yes” is marked indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

 

 

 

 

 

 

Attached to Registrant’s Form 6-K for the month of May 2019 and incorporated by reference herein is the Registrant’s immediate report dated May 23, 2019.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to signed on its behalf by the undersigned, thereunto duly authorized.

 

  (Registrant)
     
By: /s/ Guy Bernstein
    Guy Bernstein CEO
    dated: May 23, 2019

 

2

 

 

Exhibit Index

 

Exhibit No.   Description
99.1   Press Release

 

 

 

3

 

 

 

Exhibit 99.1

 

PRESS RELEASE

Formula Systems Reports First Quarter 2019 Results

 

Operating income for the first quarter increased 23% year over year to $31.7 million. Net income attributable to Shareholders increased 39% year over year to $10.0 million

 

Or Yehuda, Israel, May 23, 2019Formula Systems (1985) Ltd. (NASDAQ: FORTY), a global information technology holding company engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products, today announced its results for the first quarter ended March 31, 2019.

 

Financial Highlights for the First Quarter Ended March 31, 2019

 

Consolidated revenues for the first quarter increased by 4.8% to $391.4 million, with growth recorded across Formula’s entire investment portfolio. Revenues for the first quarter ended March 31, 2018 amounted to $373.4 million. On a constant currency basis, excluding the negative impact from the erosion of foreign exchange rates, revenues for the first quarter would have reflected an increase of 8% year over year to a record-breaking $403 million.

 

Consolidated operating income for the first quarter increased by 22.8% to $31.7 million, with growth recorded across Formula’s entire investment portfolio. Consolidated operating income for the first quarter ended March 31, 2018 amounted to $25.8 million.

 

Consolidated net income attributable to Formula’s shareholders for the first quarter was $10.0 million, or $0.58 per fully diluted share, compared to $7.2 million, or $0.48 per fully diluted share, in the same period last year, reflecting an increase of 38.6%.

 

As of March 31, 2019 Formula held 48.88%, 48.06%, 45.16%, 100%, 50% and 90.09% of the outstanding ordinary shares of Matrix IT Ltd., Sapiens International Corporation N.V, Magic Software Enterprises Ltd., Michpal Micro Computers (1983) Ltd., TSG IT Advanced Systems Ltd. and Insync Staffing Solutions, Inc., respectively.

 

Consolidated cash and cash equivalents, bank deposits and investments in marketable securities totaled approximately $297.5 million as of March 31, 2019, compared to $295.3 million as of December 31, 2018.

  

Total equity as of March 31, 2019 was $846.3 million (representing 43.9% of the total balance sheet), compared to $805.4 million (representing 48.4% of the total balance sheet) as of December 31, 2018.

 

On March 31, 2019, Formula reported the completion of an institutional public offering of series C debentures (the “Offering”). Formula Series C debentures are secured by liens over shares of Formula’s subsidiaries that are held by Formula (with an LTV of not more than 60%). The New Debentures were listed for trading on the Tel-Aviv Stock Exchange. The Company issued a total amount of NIS 300 million par-value ($82.6 million) of the New Debentures in the Offering, bearing interest at a fixed annual rate of 2.29%, paid out on a semi-annual basis, at a price per debenture unit (each unit comprised of NIS 1,000 par value of debentures) of NIS 1,000. The principal amount of the Series C Debentures will be payable by Formula in seven annual installments from December 1, 2020 through December 1, 2026, the first five of which will each constitute 11% of the principal, and the final two of which will each constitute 22.5% of the principal.

 

 

 

 

As a result of conversions that were effected prior to the maturity of Formula Series B Convertible Debentures in March 2019, holders of Series B Convertible Debentures converted an aggregate principal par value amount of NIS 80.5 million (of which NIS 0.2 million were converted in 2018) into 545,485 ordinary shares (of which 1,556 ordinary shares were issued in 2018), constituting 3.57% of Formula’s issued and outstanding share capital (following those conversions). The remaining outstanding Series B Convertible Debentures matured on March 26, 2019, and the remaining outstanding principal of NIS 44.5 million (or $11.4 million) and interest on those debentures of $1.1 million were paid on that date

 

As of March 31, 2019 Formula was in compliance with all of its financial covenants under the debentures issued by Formula and under a loan granted by a financial institution, based on achieving the following in its consolidated financial results:

 

Covenant 1

 

oTarget equity attributable to Formula’s shareholders (excluding non-controlling interests): above $215 million.

 

oActual equity attributable to Formula’s shareholders is equal to $402 million.

 

Covenant 2

 

oTarget ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for Formula’s Series A and C secured debentures): below 65%.

 

oActual ratio of net financial indebtedness to net capitalization is equal to 9%.

 

Covenant 3

 

oTarget ratio of net financial indebtedness to EBITDA (based on the accumulated calculation for the four recent quarters): below 5.

 

oActual ratio of net financial indebtedness to EBITDA (based on the accumulated calculation for the four recent quarters) is equal to 0.52.

 

Comments of Management

 

Commenting on the results, Guy Bernstein, CEO of Formula Systems, said, “We are very pleased with our strong start to 2019, demonstrating our continued impressive momentum from previous year recorded in the first quarter across our entire investment portfolio.”

 

“Matrix delivered all-time record financial results for the first quarter of 2019 with record results in all parameters, including revenues of NIS 851.9 million (approximately $233.8 million), operating income of NIS 60.1 million (approximately $16.5 million), net income of 36.7 million (approximately $10.1 million) and EBITDA of about NIS 90 million (approximately $25.2 million). Such results are attributable to Matrix growth recorded both in Israel and in the US, organically and through acquisitions. Matrix is focused on keeping with its successful strategy of completing strategic acquisitions (such as in the case of its latest acquisition of Medatech, an integrator of Priority ERP system), executing complex ‘Mega-projects’ (such as in the case of the establishment of Israel’s national credit database for the Bank of Israel which was completed and launched at the beginning of 2019 and considered to be the largest computerization project carried out in Israel’s civil sector) and focusing on the US market”.

 

“Sapiens continued its momentum from 2018 with top line growth and increased profitability recorded during the first quarter of 2019. Sapiens revenues’ growth was mainly driven by acceleration in Sapiens’ North-American segment, specifically the strong wins in the P&C business. Sapiens’ primary growth drivers for 2019 are continued expansion in the P&C segment, a stable L&A segment and increase of cross-sales for its current customer base, all are expected to enable Sapiens to deliver its 2019 full-year guidance (non-GAAP1 revenues between $318 million and $323 million and non-GAAP operating margins between 15.2% and 15.6%).”

 

 
1These non-GAAP measures are subject to the discussion under “Non-GAAP Financial Measures” in Sapiens’ press release issued on May 6, 2019

  

2

 

 

“Magic Software continued its strong momentum from 2018, reporting a strong start to 2019. Magic Software adheres to its market positioning and strong strategy, and aspires to enrich its product offering with new, powerful and innovative technologies. A notable milestone during the first quarter of 2019 was the acquisition of PowWow SmartUX™, a leading low-code development platform for mobilizing and modernizing enterprise apps. SmartUX™ is strongly synergetic to Magic’s low-code existing solutions, and by bringing them together, Magic is able to offer to new and existing clients stronger solutions and services that are well-tuned for today’s high demand for digital transformation.”

 

“Lastly, I am pleased that during the first quarter of 2019 we successfully concluded the institutional public offering of our NIS 300 million Series C secured debentures listed for trading only on the Tel-Aviv Stock Exchange. These funds will serve to support our M&A strategy mainly in supporting the growth of our currently privately held subsidiaries and to improving our equity to debt structure.” 

 

Stand-Alone Financial Measures

 

This press release presents, further below, certain stand-alone financial measures to reflect Formula’s stand-alone financial position in reference to its assets and liabilities as the parent company of the group. These financial measures are prepared consistent with the accounting principles applied in the consolidated financial statements of the group. Such measures include investments in subsidiaries and a jointly controlled entity measured at cost adjusted by Formula’s share in the investees’ accumulated undistributed earnings and other comprehensive income or loss.

 

Formula believes that these financial measures provide useful information to management and investors regarding Formula’s stand-alone financial position. Formula’s management uses these measures to compare the Company’s performance to that of prior periods for trend analyses. These measures are also used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these stand-alone financial measures provides an additional tool for investors to use in evaluating Formula’s financial position.

 

Management of the Company does not consider these stand-alone measures in isolation or as an alternative to financial measures determined in accordance with GAAP. Formula urges investors to review the consolidated financial statements which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business or financial position.

 

About Formula

 

Formula Systems (1985) Ltd. is a global information technology company engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products.

 

For more information, visit www.formulasystems.com.

 

Press Contact:

 

Formula Systems (1985) Ltd.

+972-3-5389487

ir@formula.co.il

 

Except for any historical information contained herein, matters discussed in this press release might include forward-looking statements that involve a number of risks and uncertainties. Regarding any financial statements, actual results might vary significantly based upon a number of factors including, but not limited to, risks in product and technology development, market acceptance of new products and continuing product conditions, both locally and abroad, release and sales of new products by strategic resellers and customers, and other risk factors detailed in Formula’s most recent annual report and other filings with the Securities and Exchange Commission. These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

  

3

 

 

 

FORMULA SYSTEMS (1985) LTD.

CONSOLIDATED CONDENSED STATEMENTS OF PROFIT OR LOSS

U.S. dollars in thousands (except per share data)        

  

   Three months ended 
   March 31, 
   2019   2018 
   Unaudited 
Revenues   391,354    373,375 
Cost of revenues   303,494    290,035 
Gross profit   87,860    83,340 
           
Research and development costs, net   10,584    10,946 
Selling, general and administrative expenses   45,596    46,580 
Operating income   31,680    25,814 
           
Financial expenses, net   3,596    1,971 
Income before taxes on income   28,084    23,843 
           
Taxes on income   6,261    6,118 
Income after taxes   21,823    17,725 
           
Share of profits of companies accounted for at equity, net   726    70 
Net income   22,549    17,795 
           
Net income attributable to non-controlling interests   12,513    10,556 
Net income attributable to Formula Systems’ shareholders   10,036    7,239 
           
Earnings per share (basic)   0.68    0.49 
Earnings per share (diluted)   0.58    0.48 
           
Number of shares used in computing earnings per share (basic)   14,855,794    14,730,032 
Number of shares used in computing earnings per share (diluted)   15,587,689    15,558,711 

 

4

 

  

FORMULA SYSTEMS (1985) LTD.

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

U.S. dollars in thousands      

 

   March 31,   December 31, 
   2019   2018 
   (Unaudited)       
ASSETS        
CURRENT ASSETS:        
Cash and cash equivalents   278,907    268,492 
Short-term deposits   9,466    16,881 
Marketable securities   9,140    9,913 
Trade receivables   434,721    441,468 
Other accounts receivable and prepaid expenses (*)   137,361    40,397 
Inventories   3,978    3,882 
Total current assets   873,573    781,033 
           
LONG-TERM ASSETS:          
Deferred taxes   15,854    14,214 
Other long-term accounts receivable and prepaid expenses   25,591    23,121 
Total long-term assets   41,445    37,335 
           
INVESTMENTS IN COMPANIES ACCOUNTED FOR AT EQUITY METHOD   26,685    25,710 
           
PROPERTY, PLANTS AND EQUIPMENT, NET   32,664    29,182 
           
OPERATING LEASE RIGHT-OF-USE ASSETS   102,503    - 
           
NET INTANGIBLE ASSETS AND GOODWILL   851,812    790,901 
           
TOTAL ASSETS   1,928,682    1,664,161 
           
CURRENT LIABILITIES:          
Credit from banks and others   136,943    71,180 
Debentures   20,279    55,822 
Current maturities of operating lease liabilities   30,809    - 
Trade payables   107,775    118,786 
Deferred revenues   81,665    59,509 
Other accounts payable   171,398    168,873 
Dividend payable   -    5,015 
Liabilities in respect of business combinations   5,052    5,602 
Put options of non-controlling interests   42,131    40,926 
Total current liabilities   596,052    525,713 
           
LONG-TERM LIABILITIES:          
Loans from banks and others   122,570    139,527 
Debentures   188,093    114,902 
Long-term operating lease liabilities   75,930    - 
Other long-term liabilities   7,271    8,734 
Deferred taxes   35,965    34,800 
Deferred revenues   6,662    4,906 
Liabilities in respect of business combinations   15,003    5,625 
Put options of non-controlling interests   23,826    15,673 
Employee benefit liabilities   10,985    8,884 
Total long-term liabilities   486,305    333,051 
           
EQUITY          
Equity attributable to Formula’s shareholders   402,165    367,630 
Non-controlling interests   444,160    437,767 
Total equity   846,325    805,397 
           
TOTAL LIABILITIES AND EQUITY   1,928,682    1,664,161 

 

5

 

 

FORMULA SYSTEMS (1985) LTD.

STAND-ALONE STATEMENTS OF FINANCIAL POSITION

U.S. dollars in thousands      

 

   March 31,   December 31, 
   2019   2018 
   (Unaudited) 
ASSETS        
CURRENT ASSETS:        
Cash and cash equivalents   10,902    31,411 
Other accounts receivable and prepaid expenses (*)   85,493    8,106 
Total current assets   96,395    39,517 
           
INVESTMENTS IN SUBSIDIARIES AND A JOINTLY CONTROLLED ENTITY (**)          
Matrix IT Ltd.   116,310    114,133 
Sapiens International Corporation N.V.   173,438    169,867 
Magic Software Enterprises Ltd.   108,151    108,829 
Other   58,634    54,316 
Total Investments in subsidiaries and a jointly controlled entity   456,533    447,145 
           
OTHER LONG-TERM RECEIVABLES   2,733    2,733 
           
PROPERTY, PLANTS AND EQUIPMENT, NET   3    3 
           
TOTAL ASSETS   555,664    489,398 
           
CURRENT LIABILITIES:          
Credit from banks and others   12,322    12,422 
Debentures   9,804    44,589 
Trade payables   118    83 
Other accounts payable   1,879    1,541 
Dividends payable   -    5,015 
Total current liabilities   24,123    63,650 
           
LONG-TERM LIABILITIES:          
Loans from banks and others   -    11,793 
Debentures   129,376    46,325 
Total long-term liabilities   129,376    58,118 
           
EQUITY   402,165    367,630 
           
TOTAL LIABILITIES AND EQUITY   555,664    489,398 

 

 

 
(*)

Other accounts receivable as of March 31, 2019 includes proceeds to be received from trustee in an amount of $82,186 (NIS 298,500), following the issuance of Formula’s debentures series C which was concluded on March 31, 2019.

 

(**)The investments’ carrying amounts are measured consistent with the accounting principles applied in the consolidated financial statements of the group and representing the investments’ cost adjusted by Formula’s share in the investees’ accumulated undistributed earnings and other comprehensive income or loss.

  

 

6